Clinical Trial Update: Lenalidomide in HTLV-1 Adult T-Cell Leukemia [Phase 2]

View source ↗

Summary

This report notes the completion of a Phase 2 trial evaluating lenalidomide in adults with HTLV-1–associated adult T-cell leukemia/lymphoma, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Leukemia Lymphoma

Drugs mentioned

• Lenalidomide (Revlimid) (lenalidomide)

Snippet

Sponsor: Columbia University | Conditions: Adult T Cell Leukemia/Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2016-04-22